Clik here to view.
Biologic Response
FDA-approved LaViv may offer long-lasting wrinkle relief, but will patients pay to wait six months or more for unknown results?When the United States Food & Drug Administration (www.fda.gov)...
View ArticlePublished Data Show “Significant Improvement” With LAVIV
Pivotal clinical trial data demonstrating the effectiveness of LAVIV (azficel-T) in the treatment of moderate-to-severe nasolabial fold wrinkles has been published by the Dermatologic Surgery journal...
View ArticleClik here to view.
Phase II Results Released for Biologic Acne Treatment
XBiotech, a privately held biotechnology company, has announced positive Phase II clinical trial results for True Human monoclonal antibody MABp1in the treatment of acne vulgaris. The trial was...
View ArticleClik here to view.
Adipose-Derived Mesenchymal Stem Cell Ratios Maintained with Age
The isolating ratio of adipose-derived mesenchymal stem cells remains the same among infants, adults and the elderly. But angiogenic factors are more highly expressed in infant stem cells than other...
View ArticleClik here to view.
Positive Data From Phase 2a Study Of Injectable Cellulite Treatment
Auxilium Pharmaceuticals has announced positive results from a randomized, double-blind Phase 2a study of injectable collagenase clostridium histolyticum (CCH) for the treatment of cellulite. The study...
View ArticleClik here to view.
Biologic Response
FDA-approved LaViv may offer long-lasting wrinkle relief, but will patients pay to wait six months or more for unknown results?When the United States Food & Drug Administration (www.fda.gov)...
View ArticlePublished Data Show “Significant Improvement” With LAVIV
Pivotal clinical trial data demonstrating the effectiveness of LAVIV (azficel-T) in the treatment of moderate-to-severe nasolabial fold wrinkles has been published by the Dermatologic Surgery journal...
View ArticleClik here to view.
Phase II Results Released for Biologic Acne Treatment
XBiotech, a privately held biotechnology company, has announced positive Phase II clinical trial results for True Human monoclonal antibody MABp1in the treatment of acne vulgaris. The trial was...
View ArticleClik here to view.
Adipose-Derived Mesenchymal Stem Cell Ratios Maintained with Age
The isolating ratio of adipose-derived mesenchymal stem cells remains the same among infants, adults and the elderly. But angiogenic factors are more highly expressed in infant stem cells than other...
View ArticleClik here to view.
Positive Data From Phase 2a Study Of Injectable Cellulite Treatment
Auxilium Pharmaceuticals has announced positive results from a randomized, double-blind Phase 2a study of injectable collagenase clostridium histolyticum (CCH) for the treatment of cellulite. The study...
View ArticleClik here to view.
Biologic Therapy Dupixent (Dupilumab) Approved For Atopic Dermatitis
The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) Injection from Regeneron Pharmaceuticals, and Sanofi for the treatment of adults with moderate-to-severe atopic dermatitis...
View ArticleNew Psoriasis Guidelines Address Comorbidities and Biologic Treatment
The American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) collaborated on—and have published—new guidelines of care for psoriasis, which are being published in the Journal...
View ArticleClik here to view.
AAD Issues Guidelines on Use of Biologics During COVID-19 Outbreak
The American Academy of Dermatology has issued the following guidance on the use of biologics during the COVID-19 outbreak:Due to the recent pandemic, there is concern about the immunomodulatory...
View Article
